444 related articles for article (PubMed ID: 29981781)
1. Expression of CCR6 and CXCR6 by Gut-Derived CD4
Godefroy E; Alameddine J; Montassier E; Mathé J; Desfrançois-Noël J; Marec N; Bossard C; Jarry A; Bridonneau C; Le Roy A; Sarrabayrouse G; Kerdreux E; Bourreille A; Sokol H; Jotereau F; Altare F
Gastroenterology; 2018 Oct; 155(4):1205-1217. PubMed ID: 29981781
[TBL] [Abstract][Full Text] [Related]
2. CD4CD8αα lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel disease.
Sarrabayrouse G; Bossard C; Chauvin JM; Jarry A; Meurette G; Quévrain E; Bridonneau C; Preisser L; Asehnoune K; Labarrière N; Altare F; Sokol H; Jotereau F
PLoS Biol; 2014 Apr; 12(4):e1001833. PubMed ID: 24714093
[TBL] [Abstract][Full Text] [Related]
3. Human CD4+CD8α+ Tregs induced by Faecalibacterium prausnitzii protect against intestinal inflammation.
Touch S; Godefroy E; Rolhion N; Danne C; Oeuvray C; Straube M; Galbert C; Brot L; Alonso Salgueiro I; Chadi S; Ledent T; Chatel JM; Langella P; Jotereau F; Altare F; Sokol H
JCI Insight; 2022 Jun; 7(12):. PubMed ID: 35536673
[TBL] [Abstract][Full Text] [Related]
4. Concomitant decrease of double-positive lymphocyte population CD4CD8αα and Faecalibacterium prausnitzii in patients with colorectal cancer.
Touchefeu Y; Duchalais E; Bruley des Varannes S; Alameddine J; Mirallie E; Matysiak-Budnik T; Le Bastard Q; Javaudin F; Rimbert M; Jotereau F; Montassier E
Eur J Gastroenterol Hepatol; 2021 Feb; 32(2):149-156. PubMed ID: 32675782
[TBL] [Abstract][Full Text] [Related]
5. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
Cook L; Stahl M; Han X; Nazli A; MacDonald KN; Wong MQ; Tsai K; Dizzell S; Jacobson K; Bressler B; Kaushic C; Vallance BA; Steiner TS; Levings MK
Gastroenterology; 2019 Dec; 157(6):1584-1598. PubMed ID: 31513797
[TBL] [Abstract][Full Text] [Related]
6. Human Blood and Mucosal Regulatory T Cells Express Activation Markers and Inhibitory Receptors in Inflammatory Bowel Disease.
Lord JD; Shows DM; Chen J; Thirlby RC
PLoS One; 2015; 10(8):e0136485. PubMed ID: 26305224
[TBL] [Abstract][Full Text] [Related]
7.
Alameddine J; Godefroy E; Papargyris L; Sarrabayrouse G; Tabiasco J; Bridonneau C; Yazdanbakhsh K; Sokol H; Altare F; Jotereau F
Front Immunol; 2019; 10():143. PubMed ID: 30787928
[TBL] [Abstract][Full Text] [Related]
8. Regional Specialisation of T Cell Subsets and Apoptosis in the Human Gut Mucosa: Differences Between Ileum and Colon in Healthy Intestine and Inflammatory Bowel Diseases.
Carrasco A; Fernández-Bañares F; Pedrosa E; Salas A; Loras C; Rosinach M; Aceituno M; Andújar X; Forné M; Zabana Y; Esteve M
J Crohns Colitis; 2016 Sep; 10(9):1042-54. PubMed ID: 26995182
[TBL] [Abstract][Full Text] [Related]
9. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
Bisping G; Lügering N; Lütke-Brintrup S; Pauels HG; Schürmann G; Domschke W; Kucharzik T
Clin Exp Immunol; 2001 Jan; 123(1):15-22. PubMed ID: 11167992
[TBL] [Abstract][Full Text] [Related]
10. Alterations in the Abundance and Co-occurrence of
Lopez-Siles M; Enrich-Capó N; Aldeguer X; Sabat-Mir M; Duncan SH; Garcia-Gil LJ; Martinez-Medina M
Front Cell Infect Microbiol; 2018; 8():281. PubMed ID: 30245977
[No Abstract] [Full Text] [Related]
11. Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease.
Brimnes J; Allez M; Dotan I; Shao L; Nakazawa A; Mayer L
J Immunol; 2005 May; 174(9):5814-22. PubMed ID: 15843585
[TBL] [Abstract][Full Text] [Related]
12. Human gut microbiota-reactive DP8α regulatory T cells, signature and related emerging functions.
Jotereau F; Alameddine J; Teusan R; Pédron A; Jouand N; Altare F; Godefroy E
Front Immunol; 2022; 13():1026994. PubMed ID: 36479125
[TBL] [Abstract][Full Text] [Related]
13. Lamina Propria CD4+LAP+ Regulatory T Cells Are Increased in Active Ulcerative Colitis but Show Increased IL-17 Expression and Reduced Suppressor Activity.
D'Ambrosio A; Cossu A; Amendola A; Zandri A; Butera A; Sanchez M; Biffoni M; Pronio A; Montesani C; Kohn A; Pica R; Boirivant M
J Crohns Colitis; 2016 Mar; 10(3):346-53. PubMed ID: 26589955
[TBL] [Abstract][Full Text] [Related]
14. Faecalibacterium prausnitzii Produces Butyrate to Maintain Th17/Treg Balance and to Ameliorate Colorectal Colitis by Inhibiting Histone Deacetylase 1.
Zhou L; Zhang M; Wang Y; Dorfman RG; Liu H; Yu T; Chen X; Tang D; Xu L; Yin Y; Pan Y; Zhou Q; Zhou Y; Yu C
Inflamm Bowel Dis; 2018 Aug; 24(9):1926-1940. PubMed ID: 29796620
[TBL] [Abstract][Full Text] [Related]
15. Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis.
Qiu X; Zhang M; Yang X; Hong N; Yu C
J Crohns Colitis; 2013 Dec; 7(11):e558-68. PubMed ID: 23643066
[TBL] [Abstract][Full Text] [Related]
16. Faecalibacterium prausnitzii Strain HTF-F and Its Extracellular Polymeric Matrix Attenuate Clinical Parameters in DSS-Induced Colitis.
Rossi O; Khan MT; Schwarzer M; Hudcovic T; Srutkova D; Duncan SH; Stolte EH; Kozakova H; Flint HJ; Samsom JN; Harmsen HJ; Wells JM
PLoS One; 2015; 10(4):e0123013. PubMed ID: 25910186
[TBL] [Abstract][Full Text] [Related]
17. Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa.
Eppinga H; Sperna Weiland CJ; Thio HB; van der Woude CJ; Nijsten TE; Peppelenbosch MP; Konstantinov SR
J Crohns Colitis; 2016 Sep; 10(9):1067-75. PubMed ID: 26971052
[TBL] [Abstract][Full Text] [Related]
18. Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses.
Rossi O; van Berkel LA; Chain F; Tanweer Khan M; Taverne N; Sokol H; Duncan SH; Flint HJ; Harmsen HJ; Langella P; Samsom JN; Wells JM
Sci Rep; 2016 Jan; 6():18507. PubMed ID: 26725514
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation.
Meenan J; Spaans J; Grool TA; Pals ST; Tytgat GN; van Deventer SJ
Gut; 1997 Feb; 40(2):241-6. PubMed ID: 9071939
[TBL] [Abstract][Full Text] [Related]
20. Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes.
Lopez-Siles M; Martinez-Medina M; Busquets D; Sabat-Mir M; Duncan SH; Flint HJ; Aldeguer X; Garcia-Gil LJ
Int J Med Microbiol; 2014 May; 304(3-4):464-75. PubMed ID: 24713205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
